{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:23:52Z","timestamp":1771550632749,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T00:00:00Z","timestamp":1438819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s12035-015-9378-9","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T01:47:49Z","timestamp":1438739269000},"page":"4431-4437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Critical Role of Rab31 in Cell Proliferation and Apoptosis in Cancer Progression"],"prefix":"10.1007","volume":"53","author":[{"given":"Yunyan","family":"Pan","sequence":"first","affiliation":[]},{"given":"Yanling","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Lijun","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Yanlin","family":"Feng","sequence":"additional","affiliation":[]},{"given":"Junyuan","family":"Yan","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,8,6]]},"reference":[{"key":"9378_CR1","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1158\/0008-5472.CAN-05-0573","volume":"65","author":"KW Cheng","year":"2005","unstructured":"Cheng KW, Lahad JP, Gray JW et al (2005) Emerging role of rabgtpases in cancer and human disease. Cancer Res 65:2516\u20132519","journal-title":"Cancer Res"},{"key":"9378_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jcmm.12403","volume":"19","author":"CE Chua","year":"2015","unstructured":"Chua CE, Tang BL (2015) The role of the small gtpase rab31 in cancer. J Cell Mol Med 19:1\u201310","journal-title":"J Cell Mol Med"},{"key":"9378_CR3","doi-asserted-by":"crossref","first-page":"e39432","DOI":"10.1371\/journal.pone.0039432","volume":"7","author":"C Jin","year":"2012","unstructured":"Jin C, Rajabi H, Pitroda S, Li A et al (2012) Cooperative interaction between the muc1-c oncoprotein and the rab31 gtpase in estrogen receptor-positive breast cancer cells. PLoS ONE 7:e39432","journal-title":"PLoS ONE"},{"key":"9378_CR4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1476-4598-11-62","volume":"11","author":"B Grismayer","year":"2012","unstructured":"Grismayer B, Solch S, Seubert B et al (2012) Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells. Mol Cancer 11:62","journal-title":"Mol Cancer"},{"key":"9378_CR5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1515\/BC.2011.166","volume":"392","author":"M Kotzsch","year":"2011","unstructured":"Kotzsch M, Dorn J, Doetzer K et al (2011) Mrna expression levels of the biological factors upar, upardel4\/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer. Biol Chem 392:1047\u20131051","journal-title":"Biol Chem"},{"key":"9378_CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1755-8794-4-49","volume":"4","author":"NV Serao","year":"2011","unstructured":"Serao NV, Delfino KR, Southey BR et al (2011) Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival. BMC Med Genom 4:49","journal-title":"BMC Med Genom"},{"key":"9378_CR7","doi-asserted-by":"crossref","first-page":"e64140","DOI":"10.1371\/journal.pone.0064140","volume":"8","author":"BW Kunkle","year":"2013","unstructured":"Kunkle BW, Yoo C, Roy D (2013) Reverse engineering of modified genes by Bayesian network analysis defines molecular determinants critical to the development of glioblastoma. PLoS ONE 8:e64140","journal-title":"PLoS ONE"},{"issue":"1","key":"9378_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2217\/cns.12.9","volume":"1","author":"EC Woolf","year":"2012","unstructured":"Woolf EC, Scheck AC (2012) Metabolism and glioma therapy. CNS Oncol 1(1):7\u201310","journal-title":"CNS Oncol"},{"key":"9378_CR9","first-page":"236","volume":"2013","author":"A Vehlow","year":"1836","unstructured":"Vehlow A, Cordes N (1836) Invasion as target for therapy of glioblastoma multiforme. Biochim Biophys Acta 2013:236\u2013244","journal-title":"Biochim Biophys Acta"},{"key":"9378_CR10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492\u2013507","journal-title":"N Engl J Med"},{"issue":"Suppl 8","key":"9378_CR11","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0959-8049(01)00267-2","volume":"37","author":"DM Parkin","year":"2001","unstructured":"Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8):S4\u2013S66","journal-title":"Eur J Cancer"},{"key":"9378_CR12","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","volume":"361","author":"SE Waggoner","year":"2003","unstructured":"Waggoner SE (2003) Cervical cancer. Lancet 361:2217\u20132225","journal-title":"Lancet"},{"key":"9378_CR13","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1158\/0008-5472.CAN-03-1855","volume":"64","author":"J Miyazawa","year":"2004","unstructured":"Miyazawa J, Mitoro A, Kawashiri S et al (2004) Expression of mesenchyme-specific gene Rab31 in squamous cell carcinomas of the oral cavity. Cancer Res 64:2024\u20132029","journal-title":"Cancer Res"},{"key":"9378_CR14","doi-asserted-by":"crossref","first-page":"11400","DOI":"10.1073\/pnas.0704372104","volume":"104","author":"S Shell","year":"2007","unstructured":"Shell S, Park SM, Radjabi AR et al (2007) Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A 104:11400\u201311405","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9378_CR15","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/sj.bjc.6600935","volume":"88","author":"C Langelotz","year":"2003","unstructured":"Langelotz C, Schmid P, Jakob C et al (2003) Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer. Br J Cancer 88:1406\u20131410","journal-title":"Br J Cancer"},{"key":"9378_CR16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1253\/circj.68.488","volume":"68","author":"H Sakamoto","year":"2004","unstructured":"Sakamoto H, Sakamaki T, Kanda T et al (2004) Vascular endothelial growth factor is an autocrine growth factor for cardiac myxoma cells. Circ J 68:488\u2013493","journal-title":"Circ J"},{"issue":"5","key":"9378_CR17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1158\/2159-8290.CD-15-0011","volume":"5","author":"AN Hata","year":"2015","unstructured":"Hata AN, Engelman JA, Faber AC (2015) The BCL2 family: key mediators of the apoptotic response to targeted anticancer therapeutics. Cancer Discov 5(5):475\u2013487","journal-title":"Cancer Discov"},{"key":"9378_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9:153\u2013166","journal-title":"Nat Rev Cancer"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9378-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9378-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9378-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:42:26Z","timestamp":1559428946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9378-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,6]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["9378"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9378-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,6]]}}}